Preclinical Exploration of the Potential Antiinflammatory Properties of the Peptide Leukotriene Antagonist ICI 204,219 (Accola™)

This publication has 17 references indexed in Scilit:

• Potent Leukotriene D₄Receptor Antagonist ICI 204/219 Given by the Inhaled Route Inhibits the Early but not the Late Phase of Allergen-induced Bronchoconstriction
  American Review of Respiratory Disease, 1993
• The Protective Effect of Inhaled Leukotriene D₄Receptor Antagonist ICI 204,219 against Exercise-induced Asthma
  American Review of Respiratory Disease, 1993
• Pre-clinical pharmacology of ICI D2138, a potent orally-active non-redox inhibitor of 5-lipoxygenase
  British Journal of Pharmacology, 1992
• Effect of the oral leukotriene antagonist, ICI 204,219, on antigen-induced bronchoconstriction in subjects with asthma
  Journal of Allergy and Clinical Immunology, 1992
• Role of Leukotrienes in Exercise-induced Asthma: Inhibitory Effect of ICI 204219, a Potent Leukotriene D₄Receptor Antagonist
  American Review of Respiratory Disease, 1992
• Effect of cysteinyl-leukotriene receptor antagonist ICI 204.219 on allergen-induced bronchoconstriction and airway hyperreactivity in atopic subjects
  The Lancet, 1991
• The Preclinical Pharmacology of ICI 204,219: A Peptide Leukotriene Antagonist
  American Review of Respiratory Disease, 1990
• L-663,536 (MK-886) (3-[1-(4-chlorobenzyl)-3-t-butyl-thio-5-isopropylindol-2-yl]-2,2-dimethylpropanoic acid), a novel, orally active leukotriene biosynthesis inhibitor
  Canadian Journal of Physiology and Pharmacology, 1989
• Pharmacology of L-660,711 (MK-571): a novel potent and selective leukotriene D₄ receptor antagonist
  Canadian Journal of Physiology and Pharmacology, 1989
• Leukotriene C: a slow-reacting substance from murine mastocytoma cells.
  Proceedings of the National Academy of Sciences, 1979